Mortality of COVID-19 patients with vascular thrombotic complications

José A Gonzalez-Fajardo1, Marina Ansuategui1, Carmen Romero2

  • 1Servicio de Medicina Preventiva, Hospital Universitario 12 de Octubre, Madrid, Spain.

Medicina Clinica (English Ed.)
|February 1, 2021
PubMed

Insights

COVID-19 patients with vascular thrombosis face high mortality, especially with arterial events like peripheral arterial thrombosis (PAT) and ischemic stroke. Venous thromboembolism (VTE) is more common, but survival is better for deep vein thrombosis (DVT) and pulmonary embolism (PE).

Area of Science:

  • Internal Medicine
  • Cardiology
  • Infectious Diseases

Background:

  • COVID-19 is associated with an increased risk of vascular thrombotic complications.
  • Understanding the specific risks and outcomes of different thrombotic events in COVID-19 patients is crucial for clinical management.

Purpose of the Study:

  • To analyze the survival rates of hospitalized COVID-19 patients who experienced vascular thrombotic complications.
  • To compare the mortality associated with different types of thrombosis, including deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and peripheral arterial thrombosis (PAT).

Main Methods:

  • A cohort of 2943 COVID-19 patients admitted between March and April 2020 was analyzed.
  • 106 patients with objectively confirmed symptomatic vascular thrombosis (DVT, PE, ischemic stroke, PAT) were identified.
  • Survival analysis was performed using Kaplan-Meier curves, Log Rank test, and Cox regression.

Main Results:

  • Vascular thrombosis occurred in 106 (3.6%) of COVID-19 patients, with PE being the most frequent (58 cases).
  • Mortality was significantly higher in patients with arterial thrombosis (PAT: 69.2%, ischemic stroke: 53.3%) compared to venous thrombosis (DVT: 5%, PE: 12.1%).
  • Overall hospital mortality for patients with vascular thrombosis was 23.58% (25 deaths).

Conclusions:

  • While venous thromboembolism (VTE) is more common in COVID-19, arterial thrombosis (AT) carries a substantially higher mortality risk.
  • Survival outcomes were poorer for patients with ischemic stroke and PAT compared to those with DVT and PE.
  • These findings highlight the critical need for vigilant monitoring and management of thrombotic complications in COVID-19 patients.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
115
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
121
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
96
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
114
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
124
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
131